benzyl (4S)-2,5-dioxo-4-propan-2-yl-1,3-oxazolidine-3-carboxylate

We are benzyl (4S)-2,5-dioxo-4-propan-2-yl-1,3-oxazolidine-3-carboxylate CAS:158257-41-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:benzyl (4S)-2,5-dioxo-4-propan-2-yl-1,3-oxazolidine-3-carboxylate
CAS.NO:158257-41-1
Synonyms:benzyl (4S)-2,5-dioxo-4-propan-2-yl-1,3-oxazolidine-3-carboxylate
(S)-Benzyl 4-isopropyl-2,5-dioxooxazolidine-3-carboxylate
Z-VAL-NCA
N-Cbz-L-valine N-Carboxyanhydride
(S)-3-(Benzyloxycarbonyl)-4-isopropyl-2,5-oxazolidinedione
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 368.0±35.0 °C at 760 mmHg
Molecular Formula C14H15NO5
Molecular Weight 277.273
Flash Point 176.4±25.9 °C
 
Specification:
Appearance:White to light tan powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Valganciclovir(CAS:175865-60-8).

benzyl (4S)-2,5-dioxo-4-propan-2-yl-1,3-oxazolidine-3-carboxylate


Related News: Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).1,3-Bis(isocyanatomethyl)benzene CAS:3634-83-1 The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.Tetrapropoxysilane Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.5788-17-0 Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.

Related Products
Product Name
3,5-xylenol View Details
Triethoxysilane View Details
4-Aminopiperidine View Details
2,5-dichloro-thiophene-3,4-dicarboxylic acid manufacturer 1-(3-methoxypropyl)piperidin-4-one manufacturer methyl 5-chloro-3-(methylsulfamoyl)thiophene-2-carboxylate manufacturer 12H-[1]benzothieno[2,3-a]carbazole manufacturer 3-butoxypropan-1-ol manufacturer